サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1784612

北米の手術用抗菌縫合糸市場の予測 (2021～2031年)：市場範囲・セグメント・動向・競合分析

North America Antimicrobial Surgical Suture Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

出版日
ページ情報
英文 111 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.26円
北米の手術用抗菌縫合糸市場の予測 (2021～2031年)：市場範囲・セグメント・動向・競合分析
出版日: 2025年07月10日
発行: The Insight Partners
ページ情報: 英文 111 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の手術用抗菌縫合糸の市場規模は、2023年の1億5,964万米ドルから2031年には3億2,952万米ドルに達すると予測されています。2024年から2031年にかけてのCAGRは9.6%を記録すると推定されます。

エグゼクティブサマリー、北米の手術用抗菌縫合糸市場分析

北米の手術用抗菌縫合糸市場は米国、カナダ、メキシコに区分されます。2023年には米国が最大シェアを占める。整形外科手術、形成外科手術、心臓血管手術、帝王切開分娩の増加により、手術用抗菌縫合糸の製造に注力する市場プレイヤーの増加が手術用抗菌縫合糸市場を牽引しています。

北米の手術用抗菌縫合糸市場のセグメンテーション分析：

手術用抗菌縫合糸市場の分析に貢献した主要セグメントは、種類、原材料、用途、エンドユーザーです。

種類別では、北米の手術用抗菌縫合糸市場はトリクロサン抗菌縫合糸とクロルヘキシジン抗菌縫合糸にサブセグメント化されます。2023年にはトリクロサン抗菌縫合糸が大きなシェアを占めています。

原材料別では、北米の手術用抗菌縫合糸市場はポリグラクチン910抗菌縫合糸、ポリグルカプロン25、ポリグリコール酸に区分されます。2023年にはポリグラクチン910抗菌縫合糸セグメントが最大シェアを占めています。

用途別では、北米の手術用抗菌縫合糸市場は心臓血管外科、一般外科、眼科外科、婦人科外科、整形外科、形成外科、獣医外科、歯科外科、その他に区分されます。2023年には、心臓血管外科セグメントが市場で最大のシェアを占めています。

エンドユーザー別では、北米の手術用抗菌縫合糸市場は病院、外来手術センター、その他に区分されます。2023年には病院セグメントが最大シェアを占めています。

北米の手術用抗菌縫合糸市場の展望

米国外科学会（American College of Surgeons）によると、世界の個人の～1～2％が生涯に一度は慢性創傷を経験する可能性があります。同様に、米国疾病予防管理センター（CDC）の推計によると、米国では医療従事者の間で毎年～38万5,000件の鋭利な傷害が発生しており、この数は1年以内に80万件に達する可能性があります。鋭利な刃物による傷害以外にも、職場や職業における傷害の種類は世界的に増加しています。国際労働機関（ILO）によると、毎年230万人が労働災害を経験し、健康や生活の質に影響を及ぼしています。慢性創傷の負担が急増するにつれ、最終的には国の医療システムによる財政負担を大幅に軽減するための高度な創傷ケア管理方法に対する需要が高まっています。様々な国が傷害の治療や関連リスクの回避に多額の資金を費やしています。例えば米国では、医療制度は毎年250億米ドル以上を創傷と関連合併症の治療に費やしています。したがって、慢性創傷の発生率の増加に伴い、手術用抗菌縫合糸の需要も世界的に増加しています。

さらに、医療の現場で行われる一般手術、心臓血管手術、整形外科手術、婦人科手術、がん手術の件数は、世界中で驚異的に増加しています。Atrial Health社が2023年に発表したデータによると、米国では毎年～30万件の心臓手術が行われています。さらに、高齢者人口の増加は、主要な治療オプションとして手術を必要とする重篤な健康状態（ヘルニアや白内障など）を助長しています。老年人口は、特にCVD、整形外科疾患、代謝疾患、神経疾患にかかりやすいです。WHOによると、世界の高齢化人口は2019年の10億人から2050年には21億人に増加すると見られています。美容整形手術は、エンターテインメント業界で働く人々の間でも一般的になっています。これらの手術は、偶発的または先天的に奇形がある患者や、外見をより魅力的にしたいと望む患者に対して行われます。したがって、病院や同様の医療機関で行われる手術の急増が、手術用抗菌縫合糸の需要を押し上げています。

北米の手術用抗菌縫合糸市場の国別インサイト

国別に見ると、北米の手術用抗菌縫合糸市場は米国、カナダ、メキシコで構成されています。2023年には米国が最大のシェアを占めています。

米国の手術用抗菌縫合糸市場は、ベーカリーや菓子類の生産増加により拡大が見込まれています。米国形成外科学会によると、2018年、米国では美容整形手術に165億米ドルが費やされました。米国の山岳/太平洋地域は美容整形手術でより有名です。米国では150万件以上の外科的美容手術と550万件以上の非外科的美容手術が実施されました。

米国では、心血管疾患（CVD）と脳卒中が莫大な健康被害をもたらしています。米国心臓病学会の報告によると、米国では約80万人が死亡しています。主な死因は冠動脈性心疾患であり、次いで脳卒中、心不全です。しかし、冠動脈性心疾患による死亡は、先進医療診断、治療、医療保険、診療報酬の認知度により、過去10年間で減少しています。そのため、医学的治療法の増加により、心臓血管外科、整形外科、美容外科の手術が増加しています。これが手術用抗菌縫合糸のニーズを煽ることになります。

北米の手術用抗菌縫合糸市場企業プロファイル

市場で事業を展開する主要企業には、Advanced MedTech Solutions Pvt. Ltd.、Cencora, Inc.（AmerisourceBergen Corporation）、Healthium Medtech Limited、Internacional Farmaceutica SA、Johnson &Johnson、Meril Life Sciences Pvt Ltd、TI Medical、Unileneなどがあります。これらの企業は、消費者に革新的な製品を提供し、市場シェアを拡大するために、事業拡大、製品革新、M&Aなど様々な戦略を採用しています。

北米の手術用抗菌縫合糸市場調査手法：

本レポートで紹介するデータの収集と分析には、以下の調査手法を採用しています：

二次調査調査プロセスは、各市場の質的・量的データを収集するために、社内外の情報源を活用した包括的な二次調査から始まります。一般的に参照される二次調査情報源は以下の通りであるが、これらに限定されるものではない：

企業のウェブサイト、年次報告書、財務諸表、ブローカーの分析、投資家のプレゼンテーション。業界専門誌、その他関連出版物政府文書、統計データベース、市場レポートニュース記事、プレスリリース、ウェブキャスト。なお、企業プロファイルに含まれる財務データはすべて米ドルに統一されています。他の通貨で報告されている企業の数値は、該当年の関連為替レートを使用して米ドルに換算されています。

1次調査：インサイト・パートナーズでは、データ分析を検証し、貴重な知見を得るために、毎年、業界利害関係者や専門家に相当数の1次インタビューを実施しています。これらの調査は、以下を目的としています：

2次調査の結果を検証し、改良します。分析チームの専門知識と市場理解を深める。市場規模、動向、成長パターン、競合力学、将来の見通しに関する考察を得る。1次調査は、様々な市場、カテゴリー、セグメント、サブセグメントを対象とし、Eメールでのやり取りや電話インタビューで実施します。参加者は通常以下の通りです：

業界利害関係者（副社長、事業開拓マネージャー、マーケット・インテリジェンス・マネージャー、国内営業マネージャー、外部専門家）、評価の専門家（リサーチアナリスト、国内営業マネージャー、評価専門家、調査アナリスト、業界固有の専門知識を持つ主要オピニオンリーダー）

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察

第3章 分析手法

  • 二次調査
  • 一次調査
    • 仮説の策定
    • マクロ経済要因分析
    • 基礎数値の動向
    • データの三角測量
    • 国レベルのデータ

第4章 北米の手術用抗菌縫合糸市場情勢

  • PEST分析

第5章 北米の手術用抗菌縫合糸市場：主要市場力学

  • 市場促進要因
    • 手術部位感染の急増
    • 慢性創傷と手術例の増加
  • 市場抑制要因
    • 縫合糸に代わる非侵襲的な方法
  • 市場機会
    • 手術用抗菌縫合糸における戦略的取り組み
  • 今後の動向
    • スマート抗菌縫合糸
  • 促進要因と抑制要因の影響

第6章 手術用抗菌縫合糸市場：北米分析

  • 北米の手術用抗菌縫合糸市場の収益（2021～2031年）
  • 北米の手術用抗菌縫合糸市場の予測分析

第7章 北米の手術用抗菌縫合糸市場分析：種類別

  • トリクロサン抗菌縫合糸
  • クロルヘキシジン抗菌縫合糸

第8章 北米の手術用抗菌縫合糸市場分析：原材料別

  • ポリグラクチン910抗菌縫合糸
  • ポリグルカプロン25
  • ポリグリコール酸

第9章 北米手術用抗菌縫合糸の市場分析：用途別

  • 心臓血管外科
  • 一般外科
  • 眼科手術
  • 婦人科外科
  • 整形外科
  • 形成外科
  • 獣医外科
  • 歯科外科
  • その他

第10章 北米の手術用抗菌縫合糸市場の分析：エンドユーザー別

  • 病院
  • 外来手術センター
  • その他

第11章 北米の手術用抗菌縫合糸市場：国別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ

第12章 業界情勢

  • 成長戦略
  • 企業シェア分析（%、2023年）

第13章 企業プロファイル

  • TI Medical
  • Healthium Medtech Limited
  • Meril Life Sciences Pvt Ltd
  • Unilene
  • Johnson & Johnson
  • Cencora, Inc.（AmerisourceBergen Corporation）
  • Advanced MedTech Solutions Pvt. Ltd.
  • Internacional Farmaceutica SA

第14章 付録

図表

List Of Tables

  • Table 1. North America Antimicrobial Surgical Suture Market Segmentation
  • Table 2. North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. United States: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 4. United States: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Raw Materials
  • Table 5. United States: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 6. United States: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 7. Canada: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 8. Canada: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Raw Materials
  • Table 9. Canada: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 10. Canada: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 11. Mexico: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 12. Mexico: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Raw Materials
  • Table 13. Mexico: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 14. Mexico: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 15. Recent Growth Strategies in North America Antimicrobial Surgical Suture Market
  • Table 16. Glossary of Terms, Antimicrobial Surgical Suture Market

List Of Figures

  • Figure 1. North America Antimicrobial Surgical Suture Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. North America Antimicrobial Surgical Suture Market - Key Market Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. North America Antimicrobial Surgical Suture Market Revenue (US$ Million), 2021-2031
  • Figure 6. North America Antimicrobial Surgical Suture Market Share (%) - by Type (2023 and 2031)
  • Figure 7. Triclosan Antimicrobial Suture: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Chlorhexidine Antimicrobial Suture: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. North America Antimicrobial Surgical Suture Market Share (%) - by Raw Materials (2023 and 2031)
  • Figure 10. Polyglactin 910 Antimicrobial Suture: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Poliglecaprone 25: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Polyglycolic Acid: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. North America Antimicrobial Surgical Suture Market Share (%) - by Application (2023 and 2031)
  • Figure 14. Cardiovascular Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. General Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Ophthalmic Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Gynaecological Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Orthopedic Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Plastic Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Veterinary Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Dental Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Others: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. North America Antimicrobial Surgical Suture Market Share (%) - by End User (2023 and 2031)
  • Figure 24. Hospitals: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 25. Ambulatory Surgical Centers: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Others: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. North America Antimicrobial Surgical Suture Market Breakdown, by Key Countries - Revenue (2023) (US$ Million)
  • Figure 28. North America Antimicrobial Surgical Suture Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 29. United States: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 30. Canada: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 31. Mexico: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031(US$ Million)
目次
Product Code: BMIRE00031797

The North America antimicrobial surgical suture market size is expected to reach US$ 329.52 million by 2031 from US$ 159.64 million in 2023. The market is estimated to record a CAGR of 9.6% from 2024-2031.

Executive Summary and North America Antimicrobial Surgical Suture Market Analysis:

The North America antimicrobial surgical sutures market is segmented into the US, Canada, and Mexico. In 2023, the US held the largest share of the market. The increasing focus of market players on manufacturing antimicrobial surgical sutures due to the rise in orthopedic surgeries, plastic surgeries, cardiovascular surgeries, and C-section deliveries drives the antimicrobial surgical sutures market.

North America Antimicrobial Surgical Suture Market Segmentation Analysis:

Key segments that contributed to the derivation of the antimicrobial surgical suture market analysis are type, raw materials, application, and end user.

Based on type, the North America antimicrobial surgical suture market is sub segmented into triclosan antimicrobial suture and chlorhexidine antimicrobial suture. The triclosan antimicrobial suture held a larger share of the market in 2023.

By raw materials, the North America antimicrobial surgical suture market is segmented into polyglactin 910 antimicrobial suture, poliglecaprone 25, and polyglycolic acid. The polyglactin 910 antimicrobial suture segment held the largest share of the market in 2023.

By application, the North America antimicrobial surgical suture market is segmented into cardiovascular surgery, general surgery, ophthalmic surgery, gynecological surgery, orthopedic surgery, plastic surgery, veterinary surgery, dental surgery, and others. The cardiovascular surgery segment held the largest share of the market in 2023.

By end user, the North America antimicrobial surgical suture market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2023.

North America Antimicrobial Surgical Suture Market Outlook

According to the American College of Surgeons, ~1-2% of individuals in the world are likely to experience chronic wounds once in their lifetime. Similarly, as per the estimates from the Centers for Disease Control and Prevention (CDC), ~385,000 sharps injuries occur among healthcare workers in the US every year, and the number is likely to reach up to 800,000 injuries within one year. Besides sharp injuries, the number of other types of workplace or occupational injuries is increasing worldwide. According to the International Labor Organization, ~2.3 million people experience work-related injuries every year, affecting their health and quality of life. The soaring burden of chronic wounds eventually propels the demand for advanced wound care management methods to substantially reduce the financial burden from national healthcare systems. Various countries spend significant amounts of money on treating injuries and avoiding associated risks. For instance, in the US, the healthcare system spends over US$ 25 billion on treating wounds and related complications every year. Therefore, with the increasing incidence of chronic wounds, the demand for antimicrobial surgical sutures is also increasing worldwide.

Further, the number of general, cardiovascular, orthopedic, gynecological, and cancer surgeries performed in healthcare settings is increasing tremendously across the world. According to the data published by Atrial Health in 2023, ~300,000 cardiac surgeries are performed in the US every year. Moreover, the growing geriatric population contributes to severe health conditions (e.g., hernia and cataracts) that require surgeries as a primary treatment option. The geriatric population is prone to CVDs, orthopedic disorders, metabolic disorders, and neurological disorders, among others. According to the WHO, the aging population across the world is likely to rise from ~1 billion in 2019 to ~2.1 billion by 2050. Aesthetic surgeries have also become common among people working in the entertainment industry. These surgeries are performed on patients who have accidental or inherent deformities and on those who wish to make their appearance more appealing. Therefore, the surging number of surgeries performed in hospitals or similar healthcare institutions is driving the demand for antimicrobial surgical sutures.

North America Antimicrobial Surgical Suture Market Country Insights

Based on country, the North America antimicrobial surgical suture market comprises the US, Canada, and Mexico. The US held the largest share in 2023.

The US antimicrobial surgical suture market is expected to proliferate owing to the increased production of bakery and confectionery The increasing surgical procedure and the rising spending on cosmetic or plastic surgeries in the US are propelling the market growth. As per the American Society of Plastic Surgeons, in 2018, US$ 16.5 Billion was spent on cosmetic procedures in the US. The Mountain/Pacific region in the US is more famous for cosmetic surgeries. More than 1,500,000 surgical cosmetic operations and more than 5,500,000 nonsurgical procedures were carried out in the US.

Cardiovascular diseases (CVDs) and stroke produce immense health burdens in the US. According to the American College of Cardiology's reports, ~800,000 deaths were noted in the United States. The primary cause of death is coronary heart disease, followed by heart stroke and heart failure. However, deaths due to coronary heart disease have declined over the past decade due to the awareness of advanced medical diagnosis, treatments, medical insurance, and reimbursements. Therefore, the rise in medical therapies has led to an increase in cardiovascular, orthopedics, and cosmetic surgeries. This, in turn, will fuel the need for antimicrobial surgical sutures.

North America Antimicrobial Surgical Suture Market Company Profiles

Some of the key players operating in the market include Advanced MedTech Solutions Pvt. Ltd.; Cencora, Inc. (AmerisourceBergen Corporation); Healthium Medtech Limited; Internacional Farmaceutica SA; Johnson & Johnson; Meril Life Sciences Pvt Ltd; TI Medical; and Unilene among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

North America Antimicrobial Surgical Suture Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

Company websites , annual reports, financial statements, broker analyses, and investor presentations. Industry trade journals and other relevant publications. Government documents , statistical databases, and market reports. News articles , press releases, and webcasts specific to companies operating in the market. Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

Primary Research The Insight Partners' conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:

Validate and refine findings from secondary research. Enhance the expertise and market understanding of the analysis team. Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects. Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

Industry stakeholders : Vice Presidents, business development managers, market intelligence managers, and national sales managers External experts : Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. North America Antimicrobial Surgical Suture Market Landscape

  • 4.1 PEST Analysis

5. North America Antimicrobial Surgical Suture Market - Key Market Dynamics

  • 5.1 Market Drivers:
    • 5.1.1 Surging Prevalence of Surgical Site Infections
    • 5.1.2 Increasing Cases of Chronic Wounds and Surgeries
  • 5.2 Market Restraints
    • 5.2.1 Non-invasive Alternatives to Stitches
  • 5.3 Market Opportunities
    • 5.3.1 Strategic Initiatives in Antimicrobial Surgical Suture
  • 5.4 Future Trends
    • 5.4.1 Smart Antimicrobial Sutures
  • 5.5 Impact of Drivers and Restraints:

6. Antimicrobial Surgical Suture Market - North America Analysis

  • 6.1 North America Antimicrobial Surgical Suture Market Revenue (US$ Million), 2021-2031
  • 6.2 North America Antimicrobial Surgical Suture Market Forecast Analysis

7. North America Antimicrobial Surgical Suture Market Analysis - by Type

  • 7.1 Triclosan Antimicrobial Suture
    • 7.1.1 Overview
    • 7.1.2 Triclosan Antimicrobial Suture: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Chlorhexidine Antimicrobial Suture
    • 7.2.1 Overview
    • 7.2.2 Chlorhexidine Antimicrobial Suture: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Antimicrobial Surgical Suture Market Analysis - by Raw Materials

  • 8.1 Polyglactin 910 Antimicrobial Suture
    • 8.1.1 Overview
    • 8.1.2 Polyglactin 910 Antimicrobial Suture: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Poliglecaprone 25
    • 8.2.1 Overview
    • 8.2.2 Poliglecaprone 25: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Polyglycolic Acid
    • 8.3.1 Overview
    • 8.3.2 Polyglycolic Acid: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Antimicrobial Surgical Suture Market Analysis - by Application

  • 9.1 Cardiovascular Surgery
    • 9.1.1 Overview
    • 9.1.2 Cardiovascular Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 General Surgery
    • 9.2.1 Overview
    • 9.2.2 General Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Ophthalmic Surgery
    • 9.3.1 Overview
    • 9.3.2 Ophthalmic Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Gynaecological Surgery
    • 9.4.1 Overview
    • 9.4.2 Gynaecological Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Orthopedic Surgery
    • 9.5.1 Overview
    • 9.5.2 Orthopedic Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.6 Plastic Surgery
    • 9.6.1 Overview
    • 9.6.2 Plastic Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.7 Veterinary Surgery
    • 9.7.1 Overview
    • 9.7.2 Veterinary Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.8 Dental Surgery
    • 9.8.1 Overview
    • 9.8.2 Dental Surgery: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.9 Others
    • 9.9.1 Overview
    • 9.9.2 Others: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

10. North America Antimicrobial Surgical Suture Market Analysis - by End User

  • 10.1 Hospitals
    • 10.1.1 Overview
    • 10.1.2 Hospitals: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Ambulatory Surgical Centers
    • 10.2.1 Overview
    • 10.2.2 Ambulatory Surgical Centers: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Others
    • 10.3.1 Overview
    • 10.3.2 Others: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)

11. North America Antimicrobial Surgical Suture Market - Country Analysis

  • 11.1 North America
    • 11.1.1 North America Antimicrobial Surgical Suture Market Overview
    • 11.1.2 North America Antimicrobial Surgical Suture Market - Breakdown, by Key Countries, 2023 and 2031 (%)
      • 11.1.2.1 United States: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.2.1.1 United States: North America Antimicrobial Surgical Suture Market Breakdown, by Type
        • 11.1.2.1.2 United States: North America Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
        • 11.1.2.1.3 United States: North America Antimicrobial Surgical Suture Market Breakdown, by Application
        • 11.1.2.1.4 United States: North America Antimicrobial Surgical Suture Market Breakdown, by End User
      • 11.1.2.2 Canada: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.2.2.1 Canada: North America Antimicrobial Surgical Suture Market Breakdown, by Type
        • 11.1.2.2.2 Canada: North America Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
        • 11.1.2.2.3 Canada: North America Antimicrobial Surgical Suture Market Breakdown, by Application
        • 11.1.2.2.4 Canada: North America Antimicrobial Surgical Suture Market Breakdown, by End User
      • 11.1.2.3 Mexico: North America Antimicrobial Surgical Suture Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.2.3.1 Mexico: North America Antimicrobial Surgical Suture Market Breakdown, by Type
        • 11.1.2.3.2 Mexico: North America Antimicrobial Surgical Suture Market Breakdown, by Raw Materials
        • 11.1.2.3.3 Mexico: North America Antimicrobial Surgical Suture Market Breakdown, by Application
        • 11.1.2.3.4 Mexico: North America Antimicrobial Surgical Suture Market Breakdown, by End User

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies
    • 12.2.1 Overview
  • 12.3 Company Market Share Analysis (%), 2023

13. Company Profiles

  • 13.1 TI Medical
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Healthium Medtech Limited
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Meril Life Sciences Pvt Ltd
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Unilene
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Johnson & Johnson
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Cencora, Inc. (AmerisourceBergen Corporation)
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Advanced MedTech Solutions Pvt. Ltd.
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Internacional Farmaceutica SA
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms